Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 23, 2009
Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patientsSaid Afqir, Nabil Ismaili, Khaoula Alaoui, et al.
Bulletin Du Cancer|November 24, 2004
[Anticancer drugs off label used of: what do the experts think about?]Isabelle Debrix, Thierry André, Annie Becker, et al.
Oxford Medical Case Reports|December 23, 2017
Breast cancer metastasis to the spleen: a case report and literature reviewMohammed El Fadli, Khaldoun Kerrou, Hasnae Alaoui Mhamdi, et al.
American Journal of Clinical Oncology|June 3, 2021
High-dose Chemotherapy in Germ Cell Cancer Patients With Brain Metastases: Experience of an Expert CenterMatthieu Delaye, Marc-Antoine Benderra, Louise Deforceville, et al.
BMC Medical Ethics|November 28, 2024
Hematologists' perspective on advance directives, a French national cross-sectional survey - the ADORE-H studyK Serey, A Cambriel, Adrien Pollina-Bachellerie, et al.
Bulletin Du Cancer|May 19, 2005
[Dose density and dose intensity in the treatment of breast cancer]Pierre Saintigny, Sabine Assouad, Joseph Gligorov, et al.
American Journal of Obstetrics and Gynecology|October 4, 2015
Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13Pierre-Adrien Bolze, Cécilia Riedl, Jérôme Massardier, et al.
Medicina (Kaunas, Lithuania)|January 23, 2020
Integrative Medicine in Interventional Oncology: A Virtuous AllianceFrançois H Cornelis, Milan Najdawi, Mohamed Ben Ammar, et al.
Plos One|January 8, 2020
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapiesAlexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, et al.
Bulletin Du Cancer|July 30, 2004
[Anticancer drugs use evaluation: limits of the approved labeling]Isabelle Debrix, Thierry André, Antoine Flahault, et al.
Pageof 9